Chad M Robins sold $1.3M of ADPT
CEO and Chairman at Adaptive Biotechnologies Corp. 89,265 shares at an average of $14.73, traded Nov 10, 2025, filed Nov 12, 2025.
Score components
- +25RoleCEO
- +25Trade size$1.3M at market
- 0Share of holdings soldSold 3.0% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.5%, 3m +7.7%, 6m -9.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001780649-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | SOpen-market sale Common Stock10b5-1 | -86,161 | $14.73 | $1.3M | 2,873,088 | Nov 12, 2025 |
| Nov 11, 2025 | SOpen-market sale Common Stock10b5-1 | -1,237 | $14.57 | $18k | 2,871,851 | Nov 12, 2025 |
| Nov 12, 2025 | SOpen-market sale Common Stock10b5-1 | -1,867 | $15.00 | $28k | 2,869,975 | Nov 12, 2025 |
Related signals
Other insiders at Adaptive Biotechnologies Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $948k 35,643 shares | -9% | |
| 22Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $193k 6,444 shares | -2% | |
| 22Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $758k 26,792 shares | -11% | |
| 25Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $1.0M 35,643 shares | -9% | |
| 23Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $3.2M 115,406 shares | -34% | |
| 8Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $32k 1,195 shares | -0% | |
| 40Moderate | Adaptive Biotechnologies Corp | Sharon Benzeno Chief Commercial Ofc Imm Med | $3.5M 165,802 shares | -58% | |
| 40Moderate | Adaptive Biotechnologies Corp | Michelle Renee Griffin director | $1.1M 52,084 shares | -77% | |
| 20Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $103k 5,000 shares | -1% | |
| 35Weak | Adaptive Biotechnologies Corp | Harlan S Robins Chief Scientific Officer | $1.8M 106,160 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.